Kimberly Bird, MD
Sleep Medicine · Danville, VANPI 1073506572
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 58.2% of the total. Reporting peaked in 2023 at $1,733 and has fallen 94.9% since, to $88 in 2025.
Across 21 payments — averaging $143.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$2K
- Inspire Medical Systems, Inc.$954
- GSK$90
- AstraZeneca$62
- AbbVie$40
- Jazz Pharmaceuticals Inc.$30
- plus $88 from 4 others
What the payments were for
- Travel & lodging$1,78759%
- Food & beverage$1,19740%
- Education$401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 3 | $1,759 |
| Inspire Medical Systems, Inc. | 4 | $954 |
| GSK | 5 | $90 |
| AstraZeneca | 1 | $62 |
| AbbVie | 1 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Harmony Biosciences LLC | 1 | $28 |
| Boehringer Ingelheim | 1 | $15 |
| Resmed Corp | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,023 in reported general payments places this provider in the 75th percentile of 74 sleep medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 24 | $349 |
| Azithromycin | 14 | $188 |
| Gabapentin | 18 | $115 |
| Prednisone | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Danville
- William WinterCharlottesville$1.1M
- Michael PolskyNorth Chesterfield$99K
- Astaad DalalFalls Church$99K
- Douglas PuryearMidlothian$49K
- Marc RaphaelsonLeesburg$47K
- Shahriar ShahzeidiLeesburg$27K
- Pascal NgongmonWoodbridge$25K
- Amit PatelFalls Church$14K
- Richard ParisiWilliamsburg$8K
- Vandana DhawanChesapeake$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.